BioInvent proposes rights offering

BioInvent International AB (SSE:BINV), Lund, Sweden Business: Cardiovascular, Cancer, Antibodies Date announced: 6/19/13 Type: Rights offering To be raised: Up to SEK22.2 million ($3.4 million) Shares...